基本信息
浏览量:21
职业迁徙
个人简介
Breast cancer is a heterogeneous disease with a large variability in clinical outcome. Around two thirds of all breast cancer patients are cured by surgery as single treatment modality. Thus only one third need additional medical therapy, which today however, is delivered to 80-90% of the patients. Our selection criteria for low- and high-risk patients need consequently to be improved. The choice of adjuvant therapy should ideally be based on treatment predictive factors. So far, only a few factors are in clinical use; estrogen (ER) receptor for the choice of endocrine therapy, and the growth factor receptor (HER2) for anti-HER2 therapy. Generally accepted, clinically useful markers for predicting the sensitivity to chemo- and radiotherapy are still lacking. Finding molecular signatures for the identification of patients who could be spared chemotherapy is considered to have the highest priority among breast cancer specialists world-wide.
Using immunohistochemistry we are, in clinically well-defined materials, evaluating the importance of, for example: biomarkers involved in proliferation, the mTOR signaling pathway, ALDH1 (a stem cell marker), IGF1R, AIB1 (a co-factor for ER) and GPER1 (G-protein-coupled estrogen receptor) as well as apoptotic markers. Techniques within whole genome sequencing and gene profiling are also applied
Using immunohistochemistry we are, in clinically well-defined materials, evaluating the importance of, for example: biomarkers involved in proliferation, the mTOR signaling pathway, ALDH1 (a stem cell marker), IGF1R, AIB1 (a co-factor for ER) and GPER1 (G-protein-coupled estrogen receptor) as well as apoptotic markers. Techniques within whole genome sequencing and gene profiling are also applied
研究兴趣
论文共 406 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Acta oncologica (Stockholm, Sweden)no. 1 (2024): 535-541
Terese Engstrom,Maria Ekholm,Marten Ferno,Christine Lundgren,Bo Nordenskjold,Olle Stal, Paer-Ola Bendahla,Julia Tutzauer,Lisa Ryden
Terese Engström, Maria Ekholm,Mårten Fernö,Christine Lundgren, Bo Nordenskjöld,Olle Stål,Pär-Ola Bendahl,Julia Tutzauer, Lisa Rydén
crossref(2023)
Martin Sjöström, S. Laura Chang, Nick Fishbane,Elai Davicioni, Linda Hartman,Erik Holmberg,Felix Y. Feng,Corey Speers,Lori J. Pierce, Per Malmström,Mårten Fernö,Per Karlsson
openalex(2023)
Gottfrid Sjödahl,Martin Lauss,Kristina Lövgren,Gunilla Chebil,Sigurdur Gudjonsson,Srinivas Veerla, Oliver Patschan,Mattias Aine,Mårten Fernö,Markus Ringnér,Wiking Månsson, Fredrik Liedberg, David Lindgren,Mattias Höglund
openalex(2023)
Per Karlsson,Anthony Fyles,S. Laura Chang,Bradley Arrick,Frederick Baehner,Per Malmstrom,Marten Ferno,Erik Holmberg,Martin Sjostrom,Fei-Fei Liu,David A. Cameron,Linda J. Williams,John Ms Bartlett,Joanna Dunlop,Jacqueline Caldwell,Joseph F. Loane,Elizabeth Mallon,Tammy Piper,Wilma J. Jack,Ian Kunkler,Felix Y. Feng,Corey W. Speers,Lori Pierce,John Bennett,Karen J. Taylor
CANCER RESEARCHno. 5 (2023)
Stefan Broselid, Benxu Cheng,Martin Sjöström,Kristina Lövgren, Heather L.P. Klug-De Santiago,Mattias Belting,Karin Jirström,Per Malmström, Björn Olde,Pär‐Ola Bendahl, Linda Hartman,Mårten Fernö,L.M. Fredrik Leeb-Lundberg
openalex
crossref(2023)
加载更多
作者统计
#Papers: 404
#Citation: 15224
H-Index: 62
G-Index: 111
Sociability: 7
Diversity: 3
Activity: 83
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn